Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
Deloitte
Teva
Baxter
US Department of Justice
Dow
Moodys
QuintilesIMS

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022202

« Back to Dashboard

NDA 022202 describes ZIPSOR, which is a drug marketed by Assertio and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ZIPSOR profile page.

The generic ingredient in ZIPSOR is diclofenac potassium. There are forty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
Summary for 022202
Tradename:ZIPSOR
Applicant:Assertio
Ingredient:diclofenac potassium
Patents:8
Formulation / Manufacturing:see details
Pharmacology for NDA: 022202
Suppliers and Packaging for NDA: 022202
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZIPSOR diclofenac potassium CAPSULE;ORAL 022202 NDA Depomed, Inc. 13913-008 13913-008-11 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-11)
ZIPSOR diclofenac potassium CAPSULE;ORAL 022202 NDA Depomed, Inc. 13913-008 13913-008-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-12)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Jun 16, 2009TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 15, 2019Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jul 15, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
Patent:➤ Try a Free TrialPatent Expiration:Feb 24, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
Chinese Patent Office
Baxter
AstraZeneca
Daiichi Sankyo
Argus Health
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.